Side effects of long-term use of proton pump inhibitors: practical considerations.


Journal

Polish archives of internal medicine
ISSN: 1897-9483
Titre abrégé: Pol Arch Intern Med
Pays: Poland
ID NLM: 101700960

Informations de publication

Date de publication:
29 06 2021
Historique:
pubmed: 14 5 2021
medline: 5 8 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

Proton pump inhibitors (PPIs) are among the most commonly prescribed drugs due to the increasing incidence of acid‑related disorders, but a large number of prescriptions are issued with inappropriate indications. Despite PPIs being effective and well tolerated, there have been growing concerns about potential adverse effects associated with long‑term use of these drugs. Indeed, pharmacovigilance agencies have issued broad-based product warnings on the association between treatment with PPIs and long‑term complications, including increased risk of fractures and impaired magnesium absorption. On the contrary, despite plausible underlying biological mechanisms, the available clinical evidence for most side effects is weak or contradictory, and the benefits of PPI treatment seem to outweigh the potential adverse effects. This review aims to discuss the most important and established side effects of long-term use of PPIs and provide practical considerations for their clinical management.

Identifiants

pubmed: 33982542
doi: 10.20452/pamw.15997
doi:

Substances chimiques

Proton Pump Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-549

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Chiara Castellana (C)

Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Silvia Pecere (S)

Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Center for Endoscopic Research Therapeutics and Training (CERTT), Catholic University of Rome, Rome, Italy

Manuele Furnari (M)

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy

Andrea Telese (A)

Department of Gastroenterology, University College London Hospital (UCLH), London, United Kingdom

Maria Valeria Matteo (MV)

Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Center for Endoscopic Research Therapeutics and Training (CERTT), Catholic University of Rome, Rome, Italy

Rehan Haidry (R)

Department of Gastroenterology, University College London Hospital (UCLH), London, United Kingdom

Leonardo Henry Eusebi (LH)

Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. leonardo.eusebi@unibo.it

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH